Biogen Inc. Share Price Today: Live Updates & Key Insights
Biogen Inc. share price today is $201.8, up 0.78%. The stock opened at $201.33 against the previous close of $200.62, with an intraday high of $203.25 and low of $200.49.
Biogen Inc. Share Price Chart
Biogen Inc.
Biogen Inc. Share Price Performance
Biogen Inc. Institutional Holdings
Biogen Inc. Market Status
Biogen Inc. Fundamentals
Market Cap 29618.96 M
PB Ratio 1.5652
PE Ratio 21.2747
Enterprise Value 31472.96 M
Total Assets 29439.50 M
Volume 596372
Biogen Inc. Company Financials
About Biogen Inc. & investment objective
Company Information Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for aRelapsed or refractory diffuse large B-cell lymphoma; and other anti-CD20 therapies. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; UCB; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and Sage Therapeutics, Inc., as well as collaborations with Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome; Dayra Therapeutics, Inc. to develop oral macrocyclic peptides; Vanqua Bio, Inc. for developing Vanqua's preclinical oral C5aR1 antagonist compound; City Therapeutics, Inc. to develop select novel RNAi therapies; and ALTEOGEN Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Organisation Drug Manufacturers - General
Employees 7500
Industry Drug Manufacturers - General
CEO Mr. Christopher A. Viehbacher
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Biogen Inc. FAQs
What is the share price of Biogen Inc. today?
The current share price of Biogen Inc. is $201.8.
Can I buy Biogen Inc. shares in India?
Yes, Indian investors can buy Biogen Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Biogen Inc. shares in India?
You can easily invest in Biogen Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Biogen Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Biogen Inc..
Can I buy fractional shares of Biogen Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Biogen Inc.?
Biogen Inc. has a market cap of $29618.96 M.
In which sector does Biogen Inc. belong?
Biogen Inc. operates in the Drug Manufacturers - General sector.
What documents are required to invest in Biogen Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Biogen Inc.?
The PE ratio of Biogen Inc. is 21.27 and the PB ratio is 1.57.